November 16, 2017 9:24am

AXGN is down -$2.95 or -11.85% after closing at $24.90


AxoGen (AXGN has priced an underwritten public offering of its common stock.

The offering consists of 700,000 shares being sold by AxoGen and 1,000,000 shares being sold by EW Healthcare Partners L.P., formerly named Essex Woodlands Fund IX L.P., the selling shareholder, at $21.00 per share.

In addition, AxoGen and the selling shareholder have granted the underwriters a 30-day option to purchase up to an aggregate of 255,000 shares of common stock at the same price. The offering is expected to close on or about 11/20/17, subject to satisfaction of customary closing conditions.

Leerink Partners is acting as lead book-running manager for the offering. Cantor Fitzgerald & Co. and JMP Securities are acting as co-managers.